PTGX — Protagonist Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $2.09bn
- $1.76bn
- $60.00m
- 58
- 52
- 99
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 133 | 306 | 327 | 237 | 342 |
Net Total Receivables | 7.5 | 3.82 | 5.33 | 0.052 | 10.3 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 145 | 316 | 341 | 243 | 356 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.72 | 6.41 | 6.73 | 4.63 | 2.15 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 155 | 324 | 348 | 248 | 358 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 35.4 | 40.2 | 44 | 31.2 | 21.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 75 | 44.9 | 47.7 | 32.3 | 21.3 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 80 | 280 | 300 | 216 | 337 |
Total Liabilities & Shareholders' Equity | 155 | 324 | 348 | 248 | 358 |
Total Common Shares Outstanding |